Acute myeloblastic leukemia with maturation

Israel / US / Business and Economy / Health and Medicine / Science and Tech / On Campus / Education

Hebrew U. Drug Trials Show 50% Cure Rate in Lab Mice Acute Leukemia

BioTheryX recently bought the rights to this promising drug from HU’s technology transfer company Yissum.

Word Prompt – HATZALAH – Ariel Rackowsky

E-Edition

Serials

Getzlight – Chapter II

By Ruchama Feuerman

Classifieds

Gemachs

Job Opportunities

Service Directory

Public Comm Notice

Real Estate